Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Journey Drug Patent Portfolio

Journey owns 4 orange book drugs protected by 31 US patents Given below is the list of Journey's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10398641 Compositions and methods for treating rosacea and acne 08 Sep, 2037
Active
US10849847 Compositions and methods for treating rosacea and acne 08 Sep, 2037
Active
US10004717 Glycopyrrolate salts 28 Feb, 2033
Active
US10543192 Glycopyrrolate salts 28 Feb, 2033
Active
US10548875 Glycopyrrolate salts 28 Feb, 2033
Active
US8859610 Crystalline glycopyrrolate tosylate 28 Feb, 2033
Active
US9006462 Glycopyrrolate salts 28 Feb, 2033
Active
US9259414 Glycopyrrolate salts 28 Feb, 2033
Active
US10086080 Topical tetracycline compositions 01 Oct, 2030
Active
US10137200 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses 01 Oct, 2030
Active
US10213512 Topical tetracycline compositions 01 Oct, 2030
Active
US10265404 Compositions, gels and foams with rheology modulators and uses thereof 01 Oct, 2030
Active
US10517882 Method for healing of an infected acne lesion without scarring 01 Oct, 2030
Active
US10821187 Compositions, gels and foams with rheology modulators and uses thereof 01 Oct, 2030
Active
US8865139 Topical tetracycline compositions 01 Oct, 2030
Active
US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses 01 Oct, 2030
Active
US8992896 Topical tetracycline compositions 01 Oct, 2030
Active
US9675700 Topical tetracycline compositions 01 Oct, 2030
Active
US10322186 Topical tetracycline compositions 01 Oct, 2030
Active
US10946101 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses 01 Oct, 2030
Active
US9744105 Topical glycopyrrolate formulations 18 Jul, 2030
Active
US8618160 Topical glycopyrrolate formulations 10 Dec, 2029
Active
US10052267 Topical glycopyrrolate formulations 17 Oct, 2028
Active
US7541347 Minocycline oral dosage forms for the treatment of acne 02 Apr, 2027
Active
US7544373 Minocycline oral dosage forms for the treatment of acne 02 Apr, 2027
Active
US7919483 Method for the treatment of acne 07 Mar, 2027
Active
US7790705 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
Active
US8252776 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
Active
US8268804 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
Active
US6433003 Method for treating hyperhidrosis in mammals 10 Apr, 2020 Expired
US5908838 Method for the treatment of acne 19 Feb, 2018 Expired


Given below is the list of recent legal activities going on the following drug patents of Journey.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 03 Jun, 2024 US10849847
Payment of Maintenance Fee, 4th Yr, Small Entity 03 May, 2024 US10821187
Payment of Maintenance Fee, 12th Year, Large Entity 20 Feb, 2024 US8268804 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 23 Jan, 2024 US8252776 (Litigated)
Requirement for information sent under 37 CFR 1.750 22 Jan, 2024 US8618160
Email Notification
Critical
07 Sep, 2023 US8992896
Change in Power of Attorney (May Include Associate POA)
Critical
07 Sep, 2023 US8992896
Payment of Maintenance Fee, 4th Year, Large Entity 04 Aug, 2023 US10548875
Payment of Maintenance Fee, 4th Year, Large Entity 28 Jul, 2023 US10543192
Payment of Maintenance Fee, 4th Yr, Small Entity 30 Jun, 2023 US10517882
Payment of Maintenance Fee, 8th Yr, Small Entity 22 May, 2023 US8992896
Mail-Petition Decision - Accept Late Payment of Maintenance Fees - Granted
Critical
22 May, 2023 US8992896
Petition to Accept Late Payment of Maintenance Fee Payment Filed
Critical
22 May, 2023 US8992896
Petition Decision - Accept Late Payment of Maintenance Fees - Granted
Critical
22 May, 2023 US8992896
Surcharge, Petition to Accept Pymt After Exp, Unintentional. 22 May, 2023 US8992896


Journey's Family Patents

Journey drugs have patent protection in a total of 18 countries. It has a significant patent presence in the US with 63.6% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Journey Drug List

Given below is the complete list of Journey's drugs and the patents protecting them.


1. Amzeeq

Amzeeq is protected by 12 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10398641 Compositions and methods for treating rosacea and acne 08 Sep, 2037
(12 years from now)
Active
US10849847 Compositions and methods for treating rosacea and acne 08 Sep, 2037
(12 years from now)
Active
US10086080 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active
US10137200 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses 01 Oct, 2030
(5 years from now)
Active
US10213512 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active
US10265404 Compositions, gels and foams with rheology modulators and uses thereof 01 Oct, 2030
(5 years from now)
Active
US10517882 Method for healing of an infected acne lesion without scarring 01 Oct, 2030
(5 years from now)
Active
US10821187 Compositions, gels and foams with rheology modulators and uses thereof 01 Oct, 2030
(5 years from now)
Active
US8865139 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active
US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses 01 Oct, 2030
(5 years from now)
Active
US8992896 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active
US9675700 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Amzeeq's drug page


2. Qbrexza

Qbrexza is protected by 10 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10004717 Glycopyrrolate salts 28 Feb, 2033
(8 years from now)
Active
US10543192 Glycopyrrolate salts 28 Feb, 2033
(8 years from now)
Active
US10548875 Glycopyrrolate salts 28 Feb, 2033
(8 years from now)
Active
US8859610 Crystalline glycopyrrolate tosylate 28 Feb, 2033
(8 years from now)
Active
US9006462 Glycopyrrolate salts 28 Feb, 2033
(8 years from now)
Active
US9259414 Glycopyrrolate salts 28 Feb, 2033
(8 years from now)
Active
US9744105 Topical glycopyrrolate formulations 18 Jul, 2030
(5 years from now)
Active
US8618160 Topical glycopyrrolate formulations 10 Dec, 2029
(4 years from now)
Active
US10052267 Topical glycopyrrolate formulations 17 Oct, 2028
(3 years from now)
Active
US6433003 Method for treating hyperhidrosis in mammals 10 Apr, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qbrexza's drug page


3. Ximino

Ximino is protected by 7 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7541347 Minocycline oral dosage forms for the treatment of acne 02 Apr, 2027
(2 years from now)
Active
US7544373 Minocycline oral dosage forms for the treatment of acne 02 Apr, 2027
(2 years from now)
Active
US7919483 Method for the treatment of acne 07 Mar, 2027
(2 years from now)
Active
US7790705 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
(6 months from now)
Active
US8252776 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
(6 months from now)
Active
US8268804 Minocycline oral dosage forms for the treatment of acne 24 Jun, 2025
(6 months from now)
Active
US5908838 Method for the treatment of acne 19 Feb, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ximino's drug page


4. Zilxi

Zilxi is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10213512 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active
US10265404 Compositions, gels and foams with rheology modulators and uses thereof 01 Oct, 2030
(5 years from now)
Active
US10322186 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active
US10946101 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses 01 Oct, 2030
(5 years from now)
Active
US8865139 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active
US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses 01 Oct, 2030
(5 years from now)
Active
US8992896 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active
US9675700 Topical tetracycline compositions 01 Oct, 2030
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zilxi's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List